Opseu Pension Plan Trust Fund Bristol Myers Squibb CO Transaction History

Opseu Pension Plan Trust Fund

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $144 - $85,676	1,115 Added 1.88%	60,301 $4.29 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $3.09 Million - $3.41 Million	42,577 Added 256.35%	59,186 $4.54 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $78,264 - $93,845	1,273 Added 8.3%	16,609 $1.22 Million
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $15,713 - $18,318	293 Added 1.95%	15,336 $940,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $28,638 - $33,546	-484 Reduced 3.12%	15,043 $893,000
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $219,285 - $238,801	3,542 Added 29.55%	15,527 $1.03 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $33,052 - $37,174	557 Added 4.87%	11,985 $752,000
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $18,880 - $21,395	327 Added 2.95%	11,428 $704,000
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $74,314 - $82,350	1,294 Added 13.19%	11,101 $667,000
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $991,913 - $1.16 Million	-18,094 Reduced 64.85%	9,807 $567,000
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $1.29 Million - $1.88 Million	27,901 New	27,901 $1.51 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Opseu Pension Plan Trust Fund, based on Form 13F filings with the SEC.

Stay updated on Opseu Pension Plan Trust Fund with notifications on news.